Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
STANDARD OF CARE!
I have always had a vision for this technology and stoked BIEL is the company who has a similar vision. Actually, I think their vision is far more encompassing than mine. Biel's technology will launch KT and DonJoy into another level of business far exceeding their current profit. BIEL will do this to these companies. It is BIEL extending their generous hand to specific companies all for the sake of getting this technology blitzed to market. Billions of dollars are being lost if this does not happen FAST and they know this. It will easily out perform any KT or DonJoy products that have created and sold before. Maybe I have had too many great experiences with my patients to not see a bigger picture. Working towards creating a standard of care will help reduce pain, suffering, negative side effects, reduce recovery time thus reducing length of PT needed. All this will lead to faster return to normal and help people get back to work and their normal life. Am I sharing enough to help everyone see a larger vision because I can go for days?
FOR EXAMPLE: Normal is 12 weeks recovery for Achilles tendon rupture repair with modified krackow fiberwire suture and bone anchors. It is shortened with RecoveryRX to 10 weeks with PT beginning sooner and virtually no pain through the whole experience compared to without RecoveryRX. PT is usually extremely painful after muscle wasting from 12 weeks of disuse. This means the recovery is better than when using MUCH more expensive FDA cleared graft options. Biel's less than $100 product outperforms $10,000 allografts covered by some insurances including Medicare.
ANOTHER EXAMPLE: bone on bone osteoarthritis at the ankle joint told by multiple surgeons the patient needs either an ankle implant or fusion of the ankle joint. Once placing this patient on this she is pain free for a week after one short application. This has extended the life of her body.
All of these problems solved with one undervalued technology. BIEL needs to hire me because I can sure talk their products UP! OH and I never have to prescribe more than a few days of narcotics for any surgery and mostly prescribe it to alleviate fear and to prevent more phone calls during the week. This means less side effects like constipation, blood clots and addiction complications.
MAKE RecoveryRX STANDARD OF CARE! BIEL
I have used this on muscle and skin flaps from spider bites, DM wounds and many other difficult healing wounds. My patients express pain relief and part of the pain relief comes from reduced swelling from the anti-inflammatory capability of PEMF. I did not experience much of any increase in the speed of recovery unless inflammation is the main reason the wound has delayed healing. Wounds do not heal for many reasons and often inflammation is not the main reason a wound will not heal. For example you cannot slap RecoveryRX on a bed sore and expect it to heal if you do not remove the pressure point the bed is causing. Another example is you cannot heal a chroinic diabetic wound if the blood sugar level is too high. IMO this product will not launch initially on the platform of wound care. It will launch now if marketed where it works best which is pain relief. There are times this will not provide pain relief. For example if someone is addicted to pain medication this will not remove the pain. It is important to understand the capabilities and limitations or some may have false expectations and be let down.
We need a high quality enticing educational video on RecoveryRX. I know I would like to add it to my new practice website I'm creating. Biel needs a fresh and updated website. I imagine both these things are in the works or have already been done and have a release date. It all will get revamped. It has to get a facelift.
Those who will benefit most from BIEL:
-Those who have kidney disease like those with kidney damage from COVID-19 and can’t take NSAIDS.
-Those who have liver complications and can’t take acetaminophen.
-Those with a history of cardiac problems who should not take NSAIDS.
-Those who are on blood thinners and have a history of a stroke or heart attacks and can’t take NSAIDS.
-Those who take medications which are contraindicated to taking pain meds.
-Those with high blood pressure and can’t take NSAIDS.
-Those who get constipated with codeine.
-Those who have stomach problems that don’t tolerate many oral medications.
-Those with a history of drug addiction and don’t want to take pain medications for fear of relapse.
-Those with multiple comorbidities.
There are too many people who either cannot get pain relief because of these issues OR they are risking their health by taking pain medications when they should not.
Because of these reasons I believe Biel has the power to move the dial on the longevity of life with this technology. We can save livers, kidneys and minds by not damaging them with pain medications.
As a matter of fact I get calls from patients exactly 2 days after surgery when using RecoveryRx. Remember patients have not seen their stitches yet because of the post-op bandage.
At that 2nd day phone call I get one of two questions since using RecoveryRX: “When does anesthesia wear off?” and “Did you do the surgery?". People are often anticipating pain and taking pain pills before they ever actually sense pain. Patients call because they are nervous of getting a sudden pain attack or worried I didn’t perform the surgery. I tell them anesthesia wore off 5 hours after surgery and the reason they are pain free is because of the RecoveryRX device.
Patients are usually speechless and somewhat in disbelief that it’s the device and not my amazing surgical skills. From my experience this extreme result happens maybe 30% of the time where patients feel no pain from the surgery OR recovery from PT when using RecoveryRx. It makes me look great and naturally gets patients to refer to me. How are we still living in a world with so much acute pain when there is such a smart, non-addictive and low priced option!?
Thank you for all those who gave feedback and sharing personal lifechanging experiences using BIEL products.
For me, a very convincing action from BIEL was their response when I requested product samples. I received an email from my surgical association. I was happy to see that BIEL was reaching out to different medical associations advertising their products. I don't think it was a paid advertisement email. It was the whole email that explained RecoveryRx and the offer to submit my medical information for free samples.
I sent the email with my information they requested. Just a few days later I received 3 product samples in a box at my office. There was no email conformation or associate reaching out to me for follow-up.
It showed me that they are really pursuing multiple avenues to get this product to patients. PEMF has made me look like a surgical god because there is such a decrease in the amount of pain and inflammation at the surgical site. I require this for surgery now and is part of my standard of care.
I'd say I get 2 post-surgical patient calls a week where before using this I'd get 10. The benefits are so much more than just pain relief for surgeons.
I think its time RecoveryRx is standard of care for all post-surgical treatment. By the way BIEL is setting itself up I believe this will happen.
Watch the video that KT posted back October 2020. They already have athletes available for advertising. Now just needing a new promotional video which I have no doubt is being or has been created.
Learn how Kerri Walsh Jennings & Brooke Sweat use KT Tape to help them Train Longer. & Finish Stronger.
All OTCQB companies must meet the minimum bid price of $.01 per share at the close of business of at least one of the previous thirty (30) consecutive calendar days; in the event that the price falls below $.01, the company will begin a grace period of 180 calendar days to maintain a closing bid price of $.01 for ten consecutive trading days
Reverse Split coming?
I did not know about Regenesis. But hearing that gives me encouragement that we will get SofPulse attached to that reimbursement code. What I don’t understand is why you’re so negative about not having enough studies with PEMF when another company has been approved. I respect your history and thank you for sharing. Where I think the real gem is with pain and inflammation due to trauma. Wound care is a big market, but is Roma the answer? Apparently ENDV feels it can be, and I agree that they should pursue this avenue. Why not finish the race they’ve been running all these years.
You may be right, but I see the Roma device working differently. Nobody really understands how it’ll work yet so I don’t understand why you think you know this so well. I don’t believe this would need daily application by a doctor or a nurse. Endonovo is working on making this as simple as possible to use. A doctor will not consistently apply this for a $13 reimbursement nor will a patient need to have daily nurse applications. 30 applications per month is dreadfully unnecessary and absolutely not how this system would work. Plus if we get 70% healing in 1 week (which I am very skeptical) we wouldn’t ever make 30 applications. Are you basing the CPT code off getting a treatment from a non-portable device used back in 2008?
I don’t see much more use in responding to you. ENDV would not pursue wound care knowing they’d get $12 or $13 in reimbursement.
Absolutely. I understand your points. Medicare has set out MACRA and MIPS which if followed hospitals and clinics are being rewarded for the value they provide. These are the facilities that will rule the system in the future and it’s a reason why individual medical practices are being squashed. That being said there is a set of panic when there are patients that fail every single therapy thrown at them including surgery, auto and allografts, hyperbaric oxygen, negative pressure wound therapy (NPWT), offloading, compression,...etc. Also the longer a patient has the wound the more likely there are to have an infection and be hospitalized. There is absolutely a place in the market for this product. ENDV as far as I know has submitted a request for insurance reimbursement as of earlier last year.There does seem to be enough empirical data to request this but I don’t know how much data let’s say it took for the multi billion industry of negative pressure therapy to be approved. But NPWT is just an external device and it isn’t reimbursed as pennies. You mention $13 which I believe is super pessimistic, and I have no idea where that number comes from. I imagine the reimbursement will be similar to that of NPWT. Plus it won’t take a genius to apply and their won’t be a lot of ways to fail application as you get with NPWT. Honestly, I am very happy they are coming up with another model of the product to apply to chronic wounds. This single loop doesn’t fit chronic wounds like it fits an augmented breast. Lol
Thank you for sharing the article. Chronic wounds are a completely different subject and cannot be compared to traumatic injuries including surgery as you are aware. When insurances pay $10,000 to a hospital for a simple graft application hospitals will be quite unlikely to want to try out this miracle product. I am excited to see what their new product has to offer. Chronic diabetic ulcerations seem to be a tougher breed and need a multiple therapy approach where ENDV somewhat makes you initially think you only need their product to heal. SofPulse is generally added to the currently used therapy already being applied especially since it is yet to be covered by insurances. Hopefully this year a CPT code will be applied and used by insurances. I believe this should be the year to find out if insurances will cover!
I’m happy they are doing it right though. A double blind study is the right way to go. I have my doubts with 70% healing rate in 1 week on chronic wounds. This would put wound care companies out of business and would be a massive breakthrough. This simply isn’t the way one would announce such magnificent news. One only could wish these type of results are correct. Inflammation is only one slice of the pie which prevents chronic wounds from healing. There are so many parameters about this which need to be explained. More details please from Endonovo. Thanks for your updates and input Craig305
Markets down. We have low volume yet holding steady. We hopefully have hit bottom by now with today’s market test. Happy Veterans Day everybody!
Hardly bs. Look at the sales Ivivi had before the FDA halted their progress and later granted. This was being sold massively in multiple countries. Just wait. Sales will easily come especially after insurance accepts it. We are waiting for a CPT code even though this technology is CMS approved. Another similar product used by surgeons is the CMS covered LIPUS bone stimulator. SofPulse is following a similar trajectory as the bone stim which is already a billion dollar industry and growing. A bone stim does not prevent pain nor does it increase healing with tendons like SofPulse has shown tho. This could potentially be licensed out to a bone stim company (ie Exogen) to add to their product to reach the masses instantly and enhance their product. Maybe this is how they can get around the CPT code. Place it in a device that already has coverage. So many ways to build revenue from this. These are just some of my thoughts.
I assume this article was written so poorly because they don’t have a CMO or chief scientist anymore. Maybe this is how they are saving money?
It was such a non-specific article. We don’t know its metrics or if the p-value shows it’s statistically significant. Maybe it’s not worth spending money on further studies. By the time they report positive results in the past they have already started on their next study. I also wish they’d publish in peer reviewed journals as they were suppose to do with the mouse cardiomyopathy study. Has anyone seen that in a pier reviewed journal or heard of it being presented in any of the medical conferences?
The whole point of these past few months has been to build visibility and that’s exactly what is happening. It’s being built and getting as many people watching as possible. This is how we will get over a 100 million trades in a day and someday eventually bring us out of penny land and into the exchange. This is a very smart company. It’s only going to get out of the pennies if we have more visibility. Once we are out of the pennies then big investors can come join.
You have no idea how well SofPulse works. I believe it will surpass prescribing pain medication due to how effective it is. There should be incredible optimism surrounding what is going on here.
As weird as it is to say this I am glad ENDV has learned that giving release dates and regular company updates only drives the share price down no matter how good the news. It’s about time we see increased share price from the announcements that we have already had. It’s harder to manipulate when there aren’t these release dates and regular announcements. Welcome to penny stock land. Let’s see if this technique and others they have implemented (like paying for articles) work to increase share price.
Are they all tho? And what makes a good board because they seem to have it set up like it should be.
They have announced they're holding off on pursuing the cytotronics platform. It’s smart to stop it so they can become more laser focused. This company wouldn’t be investable if they pursued everything this treated nor is that how medical companies work. Out of all the pre-clinical trials you pick the one or two to pursue. A lot of you longs don’t understand some of the basics when investing in startup medical companies.
Also, I think you won’t find a more seasoned and well qualified group of board members to bring tPEMF to the frontline of the medical world.
And I don’t understand the daily chart reading “longs” would contribute here because that’s not what a long looks for in a company. I think some of them we had over the years were really not true longs so it’s good to see them leave this board because they were creating more havock than good.
Some bitter longs trying to sap life away when it’s not necessary. Where are the other excited longs who really love that something good is happening from this amazing technology? SofPulse in and of itself is incredible. These old jaded queens who used to love this stock have forgotten why we are all here. It’s called “long” for a reason.
He is buying shares on the open market. Done.
I’ve sold some only twice in 3 years. Been buying ever since. Never pumped or dumped as you can see with my ENDV history.
And I’ve not stopped buying. No reason to stop.
@craig305
Ill pass on anything I find out. I don’t even know if this requires that physicians write a script for it.
I have also emailed him. One of my emails was to see if I could promote SofPulse. I do not know if they have a program in place for us surgeons to be educated even more on this product and how it is sold. I know many other surgeons that might be interested in requiring their surgical candidates to buy and use this post operatively.